Beryl Cummings
of Genetics, Program Team Lead at Marea Therapeutics
San Francisco, California
Overview
Work Experience
Head of Genetics, Program Team Lead
2023 - Current
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
Raised $255,418,629.00 from Alpha Wave Global, Omega Funds, Third Rock Ventures, Surveyor Capital, Sofinnova Investments, Forbion Capital Partners, Perceptive Advisors and venBio Partners.
Senior Associate
2021 - 2024
Building Marea Therapeutics and stealth neurodegeneration newco
Human Genetics Data Scientist II
2021 - 2021
Human Genetics Data Scientist
2019 - 2021
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Raised $496,000,000.00 from Logos Capital, Frazier Life Sciences, Janus Henderson Investors and Deep Track Capital.
PhD Candidate in Laboratory of Daniel MacArthur
2015 - 2019
Spearheaded the use of transcriptome sequencing in rare disease diagnosis, including methods development and analysis, with a special focus on Mendelian neuromuscular disorders; resulted in first author publication in Science Translational Medicine. Led the development of transcript-expression aware annotation for variant interpretation, and its integration into the Genome Aggregation Dataset (gnomAD) browser and models of constraint ; resulted in first author publication in Nature. Led the analysis of mutli-nucleotide variants in the Exome Aggregation Consortium (ExAC) ; published in Nature (ExAC flagship manuscript) 2016 and Nature 2020 (gnomAD flagsip manuscript)
Research Assistant in Laboratory of Kristin Scott & Huntington F. Willard
2011 - 2014
Development of a heterochromatin inheritance assay in S.pombe to elucidate mechanisms of epigenetic inheritance at single cell resolution
Instructor, House Course
2012 - 2013
Designed and co-instructed a for-credit course to Duke undergraduates on the ethical and legal implications of genetic testing, with a special focus on direct-to-consumer genetic testing Spring 2012: HCS59: Your Future in a Test Tube Spring 2013: HCS79: Your Genes, Your Health
Research Assistant
2014 - 2014
Capstone research project drafting policy recommendations for the congresswoman on BRCA genetic testing and follow up care, with a focus was on expanding Medicare,Medicaid and ACA coverage for testing
Research Assistant, Laboratory of Jean Christophe Olivo-Marin, Unité d’Analyse d'Images Biologiques
2013 - 2013
As part of the Pasteur Foundation Fellowship Project: Understanding amoebic dysentery pathogenesis via 4D microscopy of bleb-based E. histolytica motility
Intern, Department of Education
2012 - 2012